Christopher J. Coughlin
Christopher J. Coughlin's purchase track record
Christopher J. Coughlin has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/16/2024 | CNC | $594K | +0.1% | -7.6% | -0.7% |
| 4/29/2022 | CNC | $976K | +15.4% | +6.5% | -5.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Prestige Consumer Healthcare Reports Q1 2027 Earnings. Prestige Consumer Healthcare released the transcript of its Q1 2027 earnings call. The company discussed its quarterly results and outlook, providing detailed guidance on revenue, earnings, and future plans. The release offers investors a clearer view of the company's performance and strategy.
Transaction History
| CNC | ▲ Buy | Grant | 583 | $0 | 9/30/2026 | View on chart |
| CNC | ▲ Buy | Grant | 562 | $0 | 6/30/2026 | View on chart |
| CNC | ▲ Buy | Grant | 3,992 | $0 | 5/12/2026 | View on chart |
| CNC | ▲ Buy | Grant | 1,140 | $0 | 3/31/2026 | View on chart |
| CNC | ▲ Buy | Grant | 729 | $0 | 12/31/2025 | View on chart |
| CNC | ▲ Buy | Grant | 852 | $0 | 9/30/2025 | View on chart |
| CNC | ▲ Buy | Grant | 556 | $0 | 6/30/2025 | View on chart |
| CNC | ▲ Buy | Grant | 3,579 | $0 | 5/13/2025 | View on chart |
| CNC | ▲ Buy | Grant | 500 | $0 | 3/31/2025 | View on chart |
| CNC | ▲ Buy | Grant | 497 | $0 | 12/31/2024 | View on chart |
| CNC | ▲ Buy | Open Market | 10,000 | $594K | 12/16/2024 | View on chart |
| CNC | ▲ Buy | Grant | 402 | $0 | 9/30/2024 | View on chart |
| CNC | ▲ Buy | Grant | 452 | $0 | 6/30/2024 | View on chart |
| CNC | ▼ Sell | Open Market | 878 | $67K | 5/14/2024 | View on chart |
| CNC | ▲ Buy | Grant | 2,916 | $0 | 5/14/2024 | View on chart |
| CNC | ▲ Buy | Grant | 389 | $0 | 3/31/2024 | View on chart |
| CNC | ▲ Buy | Grant | 502 | $0 | 12/31/2023 | View on chart |
| CNC | ▲ Buy | Grant | 545 | $0 | 9/30/2023 | View on chart |
| CNC | ▲ Buy | Grant | 544 | $0 | 6/30/2023 | View on chart |
| CNC | ▲ Buy | Grant | 2,947 | $0 | 5/10/2023 | View on chart |
| CNC | ▲ Buy | Grant | 511 | $0 | 3/31/2023 | View on chart |
| CNC | ▲ Buy | Grant | 444 | $0 | 12/31/2022 | View on chart |
| CNC | ▲ Buy | Grant | 406 | $0 | 9/30/2022 | View on chart |
| PBH | ▲ Buy | Grant | 2,495 | $0 | 8/2/2022 | View on chart |
| CNC | ▲ Buy | Grant | 436 | $0 | 6/30/2022 | View on chart |
| CNC | ▲ Buy | Open Market | 12,000 | $976K | 4/29/2022 | View on chart |
| CNC | ▲ Buy | Grant | 2,323 | $0 | 4/26/2022 | View on chart |
| CNC | ▲ Buy | Grant | 442 | $36K | 3/31/2022 | View on chart |
| CNC | ▲ Buy | Grant | 1,100 | $0 | 2/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Centene Expands CHOICE Arrangements in Indiana, Ohio, Oklahoma
Centene has rolled out new benefit programs that support its CHOICE arrangements in Indiana, Ohio and Oklahoma, signaling a push to broaden its managed care footprint. Analysts note the company’s turnaround still has room to grow, and its target price remains well above the current level. The broader managed‑care landscape is also shifting, with UnitedHealth reporting higher margins but lower membership, a trend that may influence competitive dynamics.
Centene Expands CHOICE Arrangements in Indiana, Ohio, Oklahoma. Centene has rolled out new benefit programs that support its CHOICE arrangements in Indiana, Ohio and Oklahoma, signaling a push to broaden its managed care footprint. Analysts note the company’s turnaround still has room to grow, and its target price remains well above the current level. The broader managed‑care landscape is also shifting, with UnitedHealth reporting higher margins but lower membership, a trend that may influence competitive dynamics.